Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS Blood and Transplant

- PMLiVE

Pfizer completes acquisition of Global Blood Therapeutics for $5.4bn

The deal includes a pipeline of sickle cell disease targeted treatments including Oxbryta

- PMLiVE

Charac teams up with NPA to expand role of independent pharmacies

The organisations aim to boost digital transformation for online pharmacy services

- PMLiVE

NHS England launches lung cancer awareness drive in country’s cancer hotspots

Only 57% of those surveyed recognised a persistent cough as a symptom of lung cancer

- PMLiVE

NHS to move ahead with Pfizer/BioNTech bivalent COVID-19 vaccine roll-out

The autumn booster programme launches today

- PMLiVE

Novo Nordisk to acquire Forma Therapeutics in deal worth $1.1bn

The acquisition will focus on expanding the company’s blood disorders portfolio

- PMLiVE

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

Wilmington Healthcare

- PMLiVE

NHS leaders urge government to take action on energy costs or risk ‘public health emergency’

There are concerns that widespread fuel poverty will increase the already high number of annual deaths associated with cold homes – estimated at around 10,000 a year

- PMLiVE

NHS England reveals COVID-19 autumn booster campaign plans

The rollout will begin in early September and see Moderna’s next generation bivalent COVID-19 vaccine offered where appropriate

- PMLiVE

bluebird bio’s beta-thalassaemia gene therapy receives FDA approval

Patients with the most severe form of the blood disorder develop life-threatening anaemia and have to receive regular blood transfusions

- PMLiVE

NHS bowel cancer checks reach record-high following death of Dame Deborah James

Between May and July 2022, over 170,500 people were referred for suspected lower gastro-intestinal cancers – up over 30,000 compared to the same period last year

- PMLiVE

NHS England outlines measures to boost capacity ahead of substantial winter pressures

The package of measures includes creating the equivalent of 7,000 additional hospital beds

- PMLiVE

Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn

The acquisition will help accelerate research into sickle cell disease

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links